Building on our previous finding of an inverse correlation between serum Alb levels and the clinical severity of visual impairment in glaucoma patients [13], we propose a novel composite biomarker: the LYMPH% multiplied by serum Alb concentration (LAP). Here, ALB is linked to glaucoma.